Advertisement
Screener

Sunshine Biopharma Inc. (SBFM) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

Sunshine Biopharma Inc. Increase (Decrease) in Accounts Receivable

Sunshine Biopharma Inc. (SBFM) reported Increase (Decrease) in Accounts Receivable of $698.21 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13

  • Sunshine Biopharma Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $88.61K.
  • Sunshine Biopharma Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $609.60K.
  • Sunshine Biopharma Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$41.29K, a 104.06% decline year-over-year.
  • Sunshine Biopharma Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $649.85K.
  • Sunshine Biopharma Inc. increase (decrease) in accounts receivable for fiscal 2025 was $116.17K, a 95.03% decline from fiscal 2024.
  • Sunshine Biopharma Inc. increase (decrease) in accounts receivable for fiscal 2024 was $2.34M, a 293.54% increase from fiscal 2023.
  • Sunshine Biopharma Inc. increase (decrease) in accounts receivable for fiscal 2023 was $594.14K, a 13.28% increase from fiscal 2022.
  • Sunshine Biopharma Inc. increase (decrease) in accounts receivable for fiscal 2022 was $524.49K, a 8816.80% increase from fiscal 2021.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 6 month as first filedIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 12 monthIncrease (Decrease) in Accounts Receivable 12 month as first filed
2026-06-30$88.61K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$698.21K
10-Q · filed 2026-08-13
$656.92K
derived: sum of 3 quarters · filed 2026-08-13
$1.31M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$609.60K
10-Q · filed 2026-05-13
$568.31K
derived: sum of 2 quarters · filed 2026-05-13
$1.22M
derived: sum of 3 quarters · filed 2026-05-13
$1.15M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$41.29K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03
$608.56K
derived: sum of 2 quarters · filed 2026-04-03
$542.85K
derived: sum of 3 quarters · filed 2026-08-13
$116.17K
10-K · filed 2026-04-03
2025-09-30$649.85K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$584.14K
derived: sum of 2 quarters · filed 2026-08-13
$157.47K
10-Q · filed 2025-11-13
$1.17M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$65.71K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$492.38K
10-Q · filed 2026-08-13
$524.64K
derived: sum of 3 quarters · filed 2026-08-13
-$462.35K
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$426.67K
10-Q · filed 2026-05-13
$590.35K
derived: sum of 2 quarters · filed 2026-05-13
-$396.64K
derived: sum of 3 quarters · filed 2026-05-13
$1.38M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03
$30.04K
derived: sum of 2 quarters · filed 2026-04-03
$1.80M
derived: sum of 3 quarters · filed 2026-04-03
$2.34M
10-K · filed 2026-04-03
2024-09-30-$986.99K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$784.91K
derived: sum of 2 quarters · filed 2025-11-13
$1.32M
10-Q · filed 2025-11-13
$1.80M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$1.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
$2.31M
10-Q · filed 2025-08-12
$1.87M
10-Q · filed 2024-08-16
$2.78M
derived: sum of 3 quarters · filed 2025-08-12
$2.85M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$536.26K
10-Q · filed 2025-05-15
$1.01M
derived: sum of 2 quarters · filed 2025-05-15
$1.08M
derived: sum of 3 quarters · filed 2025-05-15
$1.27M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$475.66K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01
$538.98K
derived: sum of 2 quarters · filed 2025-04-01
$730.03K
derived: sum of 3 quarters · filed 2025-04-01
$594.14K
10-K · filed 2025-04-01
2023-09-30$63.32K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-05
$254.37K
derived: sum of 2 quarters · filed 2024-11-05
$118.48K
10-Q · filed 2024-11-05
$650.74K
derived: sum of 4 quarters · filed 2024-11-05
2023-06-30$191.05K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2024-08-20
$55.16K
10-Q/A · filed 2024-08-20
$587.42K
derived: sum of 3 quarters · filed 2024-08-20
$587.42K
derived: sum of 4 quarters · filed 2024-08-20
2023-03-31-$135.89K
10-Q · filed 2024-05-20
$396.37K
derived: sum of 2 quarters · filed 2024-05-20
$396.37K
derived: sum of 3 quarters · filed 2024-05-20
$396.37K
derived: sum of 4 quarters · filed 2024-05-20
2022-12-31$532.26K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$532.26K
derived: sum of 2 quarters · filed 2024-03-28
$532.26K
derived: sum of 3 quarters · filed 2024-03-28
$524.49K
10-K · filed 2024-03-28
2022-09-30-$2.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
-$2.00
derived: sum of 2 quarters · filed 2023-11-13
-$7.78K
10-Q · filed 2023-11-13
-$1.11K
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
-$7.77K
10-Q · filed 2023-08-10
-$1.10K
derived: sum of 3 quarters · filed 2023-08-10
$24.00
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$7.77K
10-Q · filed 2023-05-10
-$1.10K
derived: sum of 2 quarters · filed 2023-05-10
$24.00
derived: sum of 3 quarters · filed 2023-05-10
$24.00
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$6.67K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-04
$7.80K
derived: sum of 2 quarters · filed 2023-04-04
$7.80K
derived: sum of 3 quarters · filed 2023-04-04
$5.88K
10-K · filed 2023-04-04
2021-09-30$1.13K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
$1.13K
derived: sum of 2 quarters · filed 2022-11-07
-$787.00
10-Q · filed 2022-11-07
$1.13K
derived: sum of 4 quarters · filed 2022-11-07
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
-$1.92K
10-Q · filed 2022-08-03
$0.00
derived: sum of 3 quarters · filed 2022-08-03
$0.00
derived: sum of 4 quarters · filed 2022-08-03
2021-03-31-$1.92K
10-Q · filed 2022-05-06
$0.00
derived: sum of 2 quarters · filed 2022-05-06
$0.00
derived: sum of 3 quarters · filed 2022-05-06
$0.00
derived: sum of 4 quarters · filed 2022-05-06
2020-12-31$1.92K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21
$1.92K
derived: sum of 2 quarters · filed 2022-03-21
$1.92K
derived: sum of 3 quarters · filed 2022-03-21
$1.49K
10-K · filed 2022-03-21
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$0.00
derived: sum of 2 quarters · filed 2021-11-09
-$430.00
10-Q · filed 2021-11-09
$0.00
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$430.00
10-Q · filed 2021-08-09
$0.00
derived: sum of 3 quarters · filed 2021-08-09
-$1.02K
derived: sum of 4 quarters · filed 2021-08-09
2020-03-31-$430.00
10-Q · filed 2021-05-11
$0.00
derived: sum of 2 quarters · filed 2021-05-11
-$1.02K
derived: sum of 3 quarters · filed 2021-05-11
-$24.24K
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31$430.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
-$593.00
derived: sum of 2 quarters · filed 2021-03-30
-$23.81K
derived: sum of 3 quarters · filed 2021-03-30
$430.00
10-K · filed 2021-03-30
2019-09-30-$1.02K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-12
-$24.24K
derived: sum of 2 quarters · filed 2020-11-12
$0.00
10-Q · filed 2020-11-12
-$7.94K
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30-$23.22K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31
$1.02K
10-Q/A · filed 2020-08-31
-$6.91K
derived: sum of 3 quarters · filed 2020-08-31
$16.47K
derived: sum of 4 quarters · filed 2020-08-31
2019-03-31$24.24K
10-Q · filed 2020-05-18
$16.30K
derived: sum of 2 quarters · filed 2020-05-18
$39.69K
derived: sum of 3 quarters · filed 2020-05-18
$26.81K
derived: sum of 4 quarters · filed 2020-05-18
2018-12-31-$7.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-01
$15.45K
derived: sum of 2 quarters · filed 2020-05-01
$2.56K
derived: sum of 3 quarters · filed 2020-05-01
$15.45K
10-K · filed 2020-05-01
-$15.45K
10-K · filed 2019-04-12
2018-09-30$23.38K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16
$10.50K
derived: sum of 2 quarters · filed 2019-08-15
$23.38K
10-Q · filed 2018-11-16
$23.38K
derived: sum of 4 quarters · filed 2019-08-15
2018-06-30-$12.88K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-15
$0.00
10-Q · filed 2019-08-15
$28.72K
10-Q · filed 2018-08-17
$0.00
derived: sum of 3 quarters · filed 2019-08-15
$0.00
derived: sum of 4 quarters · filed 2019-08-15
2018-03-31$12.88K
10-Q · filed 2019-05-20
$12.88K
derived: sum of 2 quarters · filed 2019-05-20
$12.88K
derived: sum of 3 quarters · filed 2019-05-20
$12.88K
derived: sum of 4 quarters · filed 2019-05-20
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-12
$0.00
derived: sum of 2 quarters · filed 2019-04-12
$0.00
derived: sum of 3 quarters · filed 2019-04-12
$0.00
10-K · filed 2019-04-12
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16
$0.00
derived: sum of 2 quarters · filed 2018-11-16
$0.00
10-Q · filed 2018-11-16
2017-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-17
$0.00
10-Q · filed 2018-08-17
2017-03-31$0.00
10-Q · filed 2018-05-22
2016-09-30$0.00
10-Q · filed 2016-11-14
2015-09-30-$1.93K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$0.00
10-Q · filed 2016-11-14
2015-06-30$1.93K
10-Q · filed 2015-08-06
2014-06-30$0.00
10-Q · filed 2015-08-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aptevo Therapeutics Inc. (APVO)United States$0.003B
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Onconetix, Inc. (ONCO)United States$0.004B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B